ConductScience.org, home

Paper5307809

The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.

Steinberg AD and 2 others. Proc Natl Acad Sci U S A, 1969. Cited by 235 papers, by iCite.

Cite this record

ConductScience Library. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Papers, record 5307809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5307809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1969
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
235
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Steinberg ADA D
2Baron SS
3Talal NN

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Anti-IdiotypicMajor topic
Antibody FormationMajor topic
Autoimmune DiseasesMajor topic
Nucleic AcidsMajor topic
Animals
Antigen-Antibody Reactions
Autoantibodies
Interferons
Mice
Nephritis
Polynucleotides
RNA

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16017796Interferon and murine leukemia. I. Inhibitory effect of interferon preparations on development of friend leukemia in mice.Proc Soc Exp Biol Med1967https://conductscience.org/library/papers/6017796PubMed
24290276Effect of statolon on Friend virus leukemia in mice.Proc Soc Exp Biol Med1967https://conductscience.org/library/papers/4290276PubMed
34167135Some factors affecting the interferon-induced antiviral state.Proc Soc Exp Biol Med1967https://conductscience.org/library/papers/4167135PubMed
45233831Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.Proc Natl Acad Sci U S A1967https://conductscience.org/library/papers/5233831PubMed
54168098Immunological studies concerning the nephritis of systemic lupus erythematosus.J Exp Med1967https://conductscience.org/library/papers/4168098PubMed
64169964Pathogenesis of the glomerulonephritis of NZB/W mice.J Exp Med1968https://conductscience.org/library/papers/4169964PubMed
74295779[Antigenicity of polynucleotide complexes].Biochim Biophys Acta1967https://conductscience.org/library/papers/4295779PubMed
84173168Family studies in systemic lupus erythematosus.Clin Exp Immunol1967https://conductscience.org/library/papers/4173168PubMed
94178111Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice.J Exp Med1969https://conductscience.org/library/papers/4178111PubMed
104179547Rapid loss of tolerance induced in weanling NZB and B-W F1 mice.Science1969https://conductscience.org/library/papers/4179547PubMed
114304105Inhibitory effect of interferon perparation on the development of foci of altered cells induced in vitro by mouse sarcoma virus.J Gen Virol1968https://conductscience.org/library/papers/4304105PubMed
124179834Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice.J Exp Med1969https://conductscience.org/library/papers/4179834PubMed
134304442Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture.J Virol1969https://conductscience.org/library/papers/4304442PubMed
145304991DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice.J Immunol1969https://conductscience.org/library/papers/5304991PubMed
154305180Further implication of murine leukemia-like virs in the disorders of NZB mice.J Exp Med1969https://conductscience.org/library/papers/4305180PubMed
164894326Inhibition of tumor growth by polyinosinic-polycytidylic acid.Proc Natl Acad Sci U S A1969https://conductscience.org/library/papers/4894326PubMed
175256404Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex.Proc Natl Acad Sci U S A1969https://conductscience.org/library/papers/5256404PubMed
185260912Antibodies to ribonucleic acid in systemic lupus erythematosus.Proc Natl Acad Sci U S A1969https://conductscience.org/library/papers/5260912PubMed
1914283274INTERFERON.Adv Virus Res1963https://conductscience.org/library/papers/14283274PubMed

Download CSV of references

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.

PMIDTitleJournalYearIn PapersSource
41301504The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy.Biomolecules2025https://conductscience.org/library/papers/41301504PubMed
39613334Interferon-α as a biomarker to predict renal outcomes in lupus nephritis.Lupus Sci Med2024https://conductscience.org/library/papers/39613334PubMed
39472388Systemic lupus erythematosus: pathogenesis and targeted therapy.Mol Biomed2024https://conductscience.org/library/papers/39472388PubMed
39452087Translating Lupus: Comparative Transcriptional Profiles of Preclinical Lupus Models and Their Relevance to Human Disease.Biology (Basel)2024https://conductscience.org/library/papers/39452087PubMed
39193187Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options.Mediterr J Rheumatol2024https://conductscience.org/library/papers/39193187PubMed
38455040Interferon autoantibodies as signals of a sick thymus.Front Immunol2024https://conductscience.org/library/papers/38455040PubMed
37047548Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.Int J Mol Sci2023https://conductscience.org/library/papers/37047548PubMed
36726783Targeting type I interferons in systemic lupus erythematous.Front Pharmacol2022https://conductscience.org/library/papers/36726783PubMed
35269647Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside.Int J Mol Sci2022https://conductscience.org/library/papers/35269647PubMed
34769174Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus.Int J Mol Sci2021https://conductscience.org/library/papers/34769174PubMed
34215365Interferons in Systemic Lupus Erythematosus.Rheum Dis Clin North Am2021https://conductscience.org/library/papers/34215365PubMed
33986670Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment.Front Pharmacol2021https://conductscience.org/library/papers/33986670PubMed
33928105Intratracheal Poly(I:C) Exposure Accelerates the Immunological Disorder of Salivary Glands in Sjogren's-Like NOD/ShiLtJ Mice.Front Med (Lausanne)2021https://conductscience.org/library/papers/33928105PubMed
33131691The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.Autoimmun Rev2020https://conductscience.org/library/papers/33131691PubMed
32079263Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement.Biomolecules2020https://conductscience.org/library/papers/32079263PubMed
31745335Interferon target-gene expression and epigenomic signatures in health and disease.Nat Immunol2019https://conductscience.org/library/papers/31745335PubMed
31725357Lupus, Silica, and Dietary Omega-3 Fatty Acid Interventions.Toxicol Pathol2019https://conductscience.org/library/papers/31725357PubMed
31450787Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.Cells2019https://conductscience.org/library/papers/31450787PubMed
31190735Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date.Drug Des Devel Ther2019https://conductscience.org/library/papers/31190735PubMed
24907379Type I interferon in the pathogenesis of lupus.J Immunol2014https://conductscience.org/library/papers/24907379PubMed

See all 61 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5307809

GET https://conductscience.org/api/papers/v1/5307809/cited_by?page=2